Bright Ideas

Bright Ideas Keith Moffat used his background in physics to tinker with tools that light up molecules in motion. By Karen Hopkin © Matthew Gilson As an undergraduate at the University of Edinburgh in the early 1960s, Keith Moffat studied physics. "Physics, physics, and more physics," he says. But when it came time to graduate, Moffat was looking to expand his horizons. Bill Cochran, a new professor who'd just arrived from Cambridge, s

Written byKaren Hopkin
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

By Karen Hopkin

As an undergraduate at the University of Edinburgh in the early 1960s, Keith Moffat studied physics. "Physics, physics, and more physics," he says. But when it came time to graduate, Moffat was looking to expand his horizons. Bill Cochran, a new professor who'd just arrived from Cambridge, suggested he get in touch with the molecular biologists there: "Francis Crick, Max Perutz, John Kendrew, folks like that," he recalls.

"So I wrote a letter asking for a brochure that would tell me the type of research going on," says Moffat. Perutz himself sent back a one-line note asking for two references. With references dispatched, Perutz's next missive, equally brief, said "come for a visit." To make the most of his time, Moffat arranged to meet with the classical physicists at the Cavendish Laboratory in the morning, and the biophysics crowd at the Laboratory of Molecular Biology in the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies